SG Americas Securities’s Dova Pharmaceuticals DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-42,853
Closed -$604K – 3368
2019
Q2
$604K Buy
+42,853
New +$408K ﹤0.01% 1769

Other funds holding DOVA

SG Americas Securities's DOVA Position: Q3 2019 in Review

SG Americas Securities sold out of Dova Pharmaceuticals (DOVA) in Q3 2019, closing a stake of 42,853 shares — an estimated $604K sold.

SG Americas Securities first reported a position in DOVA in Q2 2019 and held it in 1 quarter. The position peaked at $604K in Q2 2019. 72 funds tracked by Wall St. Rank hold DOVA as of Q3 2019.

  • SG Americas Securities reported no remaining Dova Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • SG Americas Securities sold 42,853 Dova Pharmaceuticals shares in Q3 2019, an estimated $604K.
  • SG Americas Securities first reported a position in Dova Pharmaceuticals in Q2 2019 and held it in 1 quarter.
  • SG Americas Securities's Dova Pharmaceuticals position peaked at $604K in Q2 2019.
  • 72 funds tracked by Wall St. Rank held Dova Pharmaceuticals as of Q3 2019.

Based on SG Americas Securities's 13F filing for Q3 2019, filed 4 Nov 2019.